NEW YORK--(BUSINESS WIRE)--Helaina, the biotechnology company transforming nutrition with human equivalent bioactive proteins, announced today it has raised $45 million in Series B funding, bringing the company’s total equity funding to $83 million. The round was led by Avidity Partners, with additional investment from Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity and Primary Venture Partners, among other strategic partners..

纽约--（商业新闻短讯）--Helaina，一家用人类等效生物活性蛋白转化营养的生物技术公司，今天宣布，它已经在B系列融资中筹集了4500万美元，使公司的总股本资金达到8300万美元。本轮投资由Avidity Partners牵头，Spark Capital、Ingeborg Investments、Heron Rock的Tom Williams、Barrel Ventures、暹罗资本、Relish Works、CF Private Equity和Primary Venture Partners以及其他战略合作伙伴进行了额外投资。。

The company will use the new funding to scale the availability of effera™ Human Lactoferrin, a novel ingredient to support women’s health, active nutrition and healthy aging. Helaina is selling effera™, which supports iron homeostasis and metabolism, a balanced immune response and promotes a beneficial microbiome, to consumer brands and through strategic distribution partners.

该公司将利用新资金扩大effera™人乳铁蛋白的可用性，effera™人乳铁蛋白是一种支持女性健康、活性营养和健康衰老的新型成分。Helaina正在向消费者品牌和战略分销合作伙伴销售effera™，它支持铁稳态和新陈代谢，平衡的免疫反应并促进有益的微生物群。

effera™ – the first and only human equivalent bioactive protein for nutrition to be used in functional foods, beverages and supplements – will soon be available in several consumer products, including from Kroma Wellness, The Feed, Levelle Nutrition, Healthgevity and Mitsubishi International Food Ingredients, Inc., a distributor which has deep expertise in expanding the market for nutritional ingredients with scientific rigor..

effera™是第一种也是唯一一种用于功能性食品、饮料和补充剂的人体等效营养生物活性蛋白，很快将用于多种消费品中，包括Kroma Wellness、the Feed、Levelle nutrition、Healthgevity和三菱国际食品配料有限公司（Mitsubishi International Food Components，Inc.）。三菱国际食品配料有限公司是一家在科学严谨地拓展营养配料市场方面拥有丰富专业知识的分销商。。

“This infusion of new capital marks the next phase of growth for Helaina in which we are accelerating the availability of our first ingredient through new partnerships – the result of years of work to drive innovation and scientific rigor within nutrition,” said Laura Katz, CEO and Founder, Helaina.

海莱纳州首席执行官兼创始人劳拉·卡茨（LauraKatz）表示：“新资本的注入标志着海莱纳州的下一个增长阶段，我们正在通过新的合作伙伴关系加速第一种成分的供应，这是多年来努力推动营养领域创新和科学严谨的结果。”。

“At this pivotal moment in our company’s journey, we’re proud to partner with Avidity Partners, an investment firm with an outstanding reputation for supporting best-in-class biotechnology companies rooted in clinically-backed science.”.

“在我们公司旅程的关键时刻，我们很荣幸与Avidity Partners合作，Avidity Partners是一家投资公司，因支持植根于临床支持科学的一流生物技术公司而享有盛誉。”。

Helaina was founded in 2019 by food scientist Laura Katz, who aspired to build the next generation of nutrients. Katz saw an opportunity to leverage precision fermentation to set a new standard for nutrition focused on vitality for all ages. Helaina’s technology platform powers a bioactive protein pipeline that is poised to advance the human healthspan.

Helaina由食品科学家劳拉·卡茨（LauraKatz）于2019年创立，她渴望构建下一代营养素。卡茨看到了一个利用精密发酵建立新的营养标准的机会，该标准侧重于所有年龄段的活力。Helaina的技术平台为生物活性蛋白质管道提供了动力，该管道有望促进人类健康。

Helaina is also working toward supporting health at all ages with the future launch of infant formula in partnership with formula manufacturers..

Helaina还与配方奶粉制造商合作推出婴儿配方奶粉，致力于支持所有年龄段的健康。。

“We are thrilled to support Helaina’s innovative approach to nutrition, which aligns with pressing health and wellness priorities, from immune system support to fostering a balanced gut microbiome,” said Jacob Garfield, Managing Director at Avidity Partners. “We are confident that Helaina’s technology and business model are well positioned to meet the growing demand for high quality nutritional ingredients that promote vitality across all age groups.”.

Avidity Partners董事总经理雅各布·加菲尔德（JacobGarfield）表示：“我们很高兴支持Helaina创新的营养方法，该方法符合紧迫的健康和健康优先事项，从免疫系统支持到培养平衡的肠道微生物群。”。“我们相信，Helaina的技术和商业模式能够很好地满足对高质量营养成分不断增长的需求，从而提高所有年龄段的活力。”。

About Helaina

关于海莱娜

Founded in 2019 by food scientist Laura Katz, Helaina is a biotechnology company on a mission to transform nutrition with human equivalent bioactive proteins. Developed with its precision fermentation platform, Helaina is selling effera™ to consumer brands and through strategic distribution partners; it will soon be available in consumer products, including from Kroma Wellness, The Feed, Levelle Nutrition and Healthgevity and via the distributor Mitsubishi International Food Ingredients, Inc..

Helaina由食品科学家LauraKatz于2019年成立，是一家生物技术公司，其使命是用人类等效的生物活性蛋白转化营养。凭借其精密发酵平台开发，Helaina正在向消费者品牌和战略分销合作伙伴销售effera™产品；它将很快在消费品中上市，包括Kroma Wellness、The Feed、Levelle Nutrition and Healthgevity以及分销商三菱国际食品配料有限公司。。

Based in New York City, Helaina has raised more than $83 million from leading investors, including Avidity Partners, Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity and Primary Venture Partners, among others. To learn more visit https://www.myhelaina.com or follow along on LinkedIn..

总部位于纽约市的Helaina从主要投资者那里筹集了8300多万美元，其中包括Avidity Partners、Spark Capital、Ingeborg Investments、Heron Rock的Tom Williams、Barrel Ventures、暹罗资本、Relish Works、CF Private Equity和Primary Venture Partners等。要了解更多信息，请访问https://www.myhelaina.com或者关注LinkedIn。。